Johnson & Johnson COVID Vaccine Paused
April 13, 2021
On April 13, the CDC and FDA recommended a temporary pause in the use of the Johnson & Johnson COVID-19 vaccine out of an abundance of caution. Of more than 6.8 million doses administered nationally, there have been six reported cases of a rare and severe type of blood clot with symptoms occurring 6 to 13 days after vaccination.
California is following the FDA and CDC's recommendation and has directed health care providers to pause the use of the Johnson & Johnson vaccine until we receive further direction from health and safety experts. Additionally, the state will convene the Western States Scientific Safety Review Workgroup to review the information provided by the federal government on this issue.
If you have received the Johnson & Johnson COVID-19 vaccine, and develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination, contact your healthcare provider, or seek medical care.
If you are scheduled to receive the Johnson & Johnson COVID-19 vaccine, please contact your healthcare provider, vaccination location, or clinic to learn about additional vaccine availability.
For more information about the adverse effects, and what to do if you are experiencing symptoms, please contact your healthcare provider. CDPH will provide additional details on what this means for California's efforts as they become available.